Maxime Bour
Impact in
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria
-
- Antibiotic Use and Resistance
Papers in
-
- Antibiotic Resistance in Bacteria 19
-
- Antibiotics Pharmacokinetics and Efficacy 5
- Co-authors
- Patrick Plésiat (15 shared papers)Katy Jeannot (11 shared papers)Marisa Haenni (4 shared papers)Jean-Yves Madec (4 shared papers)Pierre Châtre (2 shared papers)Émilie Gay (2 shared papers)Véronique Métayer (1 shared paper)Anaïs Potron (7 shared papers)
- Journals
- Journal of Antimicrobial Chemotherapy (4 papers)Frontiers in Microbiology (4 papers)Antimicrobial Agents and Chemotherapy (3 papers)International Journal of Antimicrobial Agents (3 papers)Clinical Microbiology and Infection (1 paper)
- Partner nations
- FranceUnited KingdomRéunion
In The Last Decade
Maxime Bour
18 papers receiving 332 citations
Peers
Comparison fields: 5 of 40
- Molecular Medicine 258
- Applied Microbiology and Biotechnology 39
- Endocrinology 71
- Pollution 64
- Clinical Biochemistry 33
Countries citing papers authored by Maxime Bour
This map shows the geographic impact of Maxime Bour's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maxime Bour with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maxime Bour more than expected).
Fields of papers citing papers by Maxime Bour
This network shows the impact of papers produced by Maxime Bour. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maxime Bour. The network helps show where Maxime Bour may publish in the future.
Co-authors
The 25 scholars most cited alongside Maxime Bour, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 52 | |
| 2 | 2014 | 46 | |
| 3 | 2017 | 44 | |
| 4 | 2019 | 29 | |
| 5 | 2019 | 24 | |
| 6 | 2022 | 20 | |
| 7 | 2019 | 18 | |
| 8 | 2021 | 14 | |
| 9 | 2023 | 14 | |
| 10 | 2023 | 13 | |
| 11 | 2019 | 13 | |
| 12 | 2022 | 11 | |
| 13 | 2023 | 10 | |
| 14 | 2023 | 10 | |
| 15 | 2024 | 8 | |
| 16 | 2019 | 7 | |
| 17 | 2023 | 4 | |
| 18 | 2022 | 1 | |
| 19 | 2024 | 0 | |
| 20 | 2025 | 0 |
About Maxime Bour
Maxime Bour is a scholar working on Molecular Medicine, Pharmacology, Endocrinology, Molecular Biology and Pollution, having authored 20 papers that have together received 338 indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (19 papers), Antibiotics Pharmacokinetics and Efficacy (5 papers), Bacterial biofilms and quorum sensing (4 papers), Vibrio bacteria research studies (3 papers), Bacterial Genetics and Biotechnology (3 papers), Pharmaceutical and Antibiotic Environmental Impacts (3 papers), Pneumonia and Respiratory Infections (3 papers) and Bacterial Identification and Susceptibility Testing (2 papers). The work is most often cited by research in Molecular Medicine (258 citations), Applied Microbiology and Biotechnology (39 citations), Endocrinology (71 citations), Pollution (64 citations) and Clinical Biochemistry (33 citations). Maxime Bour has collaborated with scholars based in France, United Kingdom and Réunion. Frequent co-authors include Patrick Plésiat, Katy Jeannot, Marisa Haenni, Jean-Yves Madec, Pierre Châtre, Émilie Gay, Véronique Métayer, Anaïs Potron, Cédric Muller and Jérôme Lemoine. Their work appears in journals such as Journal of Antimicrobial Chemotherapy, Frontiers in Microbiology, Antimicrobial Agents and Chemotherapy, International Journal of Antimicrobial Agents and Clinical Microbiology and Infection.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.